Reprocell
Kanagawa, Japanreprocell.comFrom their website, Nov 2026
- GLP
- GMP
Work here? Claim this listing
About
REPROCELL provides clinical and preclinical research services for cell therapy developers, stem cell researchers, diagnostic developers, preclinical drug developers, and clinical drug developers. It operates across REPROCELL USA, REPROCELL Europe, REPROCELL Japan, and Bioserve India, with services spanning stem cell manufacturing, gene editing, genomic analysis, human tissue assays, drug discovery assays, and biospecimen processing.
Services
Clinical Stem Cell Services
Provides clinical-grade stem cell and gene editing services for translational development.
Cell line development
GMP iPSC Production Service
Produces clinical-grade human iPSCs and GMP master cell banks.
Cell line development
StemEdit License-Free Gene Editing
Offers gene editing services for stem cell and research applications.
Cell line development
Genomic & Bioinformatics Services
Provides genomic and bioinformatics support for stem cell and clinical development programs.
GMP iPSC & iMSC MCB Manufacturing
Manufactures GMP master cell banks for iPSCs and iMSCs in the USA.
Cell line development
GMP iPSC & MSC MCB Manufacturing
Manufactures GMP master cell banks for iPSCs and MSCs through Histocell in Europe.
Cell line development
GMP Manufacturing Facility
Operates a GMP manufacturing facility in Japan for stem cell products.
Cell line development
GMP-grade iMSC & MSC production
Produces GMP-grade iMSCs and MSCs.
Cell line development
12 more services
- iPSC-Derived Exosome Production Service
- Human Tissue Assays
- Drug Discovery Assays
- Bioengineered 3D Tissue Models
- Biospecimen Processing
- Whole Blood Processing
- Cellular Services
- Central Lab Services
- Biomarker Services
- Molecular Services
- Project Management
- Nucleic Acid Extraction
Capabilities
- Assays and studies
- Cell therapy
- Bioreactors
- qPCR
- NGS
- CRISPR
- Human tissue assays
6 more
- Real-time PCR
- Next-generation sequencing
- Biomarker discovery and validation
- Nucleic acid extraction
- Neoantigen detection
- Drug discovery assays
- Therapeutic areas
- Regenerative medicine
Instruments and platforms
- ABLE Biott Bioreactor Systems
- BioThrust Bioreactor Systems
- 2mag bioMix Stirrers
Modalities and species
- Modalities
- Antibody
- Oligonucleotide
- Cell therapy
- Gene editing
- Species and models
- Human
- iPSC
- iMSC
- MSC
- B2M/CIITA cell lines
Certifications
As the company states them, with the certificate or registry record where there is one.
GLPSelf-reported
GMPSelf-reported
Scope: iPSCs, iMSCs, MSCs, and master cell bank manufacturing
Company
- Type
- CRDMO
- Founded
- 2002
- Ownership
- Small business · Minority-owned, as registered with SAM.gov or stated on their site
Locations
- Office
- 9000 Virginia Manor Road, Suite 207, Beltsville, MD 20705, USA
- Sites
- United States, USA
- Serves
- Americas, EMEA, India
- MHRA GLP site
- Reprocell Europe Limited, Glasgow, GB source